G03GA06 • follitropin beta • Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants
Follitropin beta is a recombinant follicle-stimulating hormone used in fertility treatments to stimulate the ovaries in women undergoing assisted reproductive procedures such as in vitro fertilization (IVF). This medication helps develop and mature ovarian follicles, increasing the chances of achieving pregnancy.
It is administered by subcutaneous injection, following a protocol set by the fertility specialist. The dose is individually adjusted based on the body's response and careful monitoring during treatment. It is essential for patients to strictly follow medical instructions to maximize the therapy's effectiveness.
Side effects may include injection site reactions, headaches, bloating, abdominal discomfort, or, more rarely, ovarian hyperstimulation syndrome, which requires medical attention. Mood changes or allergic reactions may also occur.
Follitropin beta is an effective and modern option for women with conception difficulties, but the treatment must be closely supervised by the medical team to prevent complications and ensure the best outcomes.
Substance: follitropin beta
Date of last drug list: 01-07-2013
Commercial code: W43248001
Concentration: 150UI / 0.18ml
Pharmaceutical form: injectible solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).